Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...
FDA rejects all in vitro study data from Raptim Research due to data falsification, requiring companies to redo studies ...
This Product is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older.
According to research, Black women are more likely to have an early onset of menopause and experience symptoms longer during ...
According to IQVIATM sales data for the 12-month period ending January 2025, the Vancomycin Hydrochloride for Injection USP, ...
As healthcare evolves at a remarkable pace, innovation in pharmaceuticals has become more than a matter of science but rather a matter of public impact. Few scientists embody this convergence better ...
Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for Acetaminophen Injection, 10 mg/mL (500mg/50mL and 1000mg/100mL) Bags.
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial). Glenmark's Vancomycin ...
4 天
MT Newswires on MSNIndian Equities Slip on Thursday as US Tariff Impact WeighsIndian markets closed lower on Thursday as investors reacted to US President Donald Trump's announcement of a 26% tariff on ...
On Thursday, 2813 stocks advanced, 1169 declined and 141 remained unchanged, with an advance decline ratio of 2.40 on the Bombay Stock Exchange (BSE), indicating positive closing of stocks in broader ...
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Vancomycin Hydrochloride for Injection USP, 750 ...
(RTTNews) - Glenmark Pharmaceuticals Inc., USA, affiliated to India-based Glenmark Pharmaceuticals Ltd., announced Tuesday the launch of Vancomycin Hydrochloride for Injection USP in single-dose ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果